New research highlights NHS approval gap compared to other cancers
News
Datapharm collaborates with VIDAL to improve medicines information access in France
New partnership to integrate SRD search technology
Brainomix partners with Medtronic to enhance stroke care
New collaboration aims to integrate AI solutions for treatment
Microbiotica unveils new data on MB097 at AACR IO meeting
Data presented in Los Angeles showcases therapy’s potential
Mitazalimab shows promising survival rates in cancer study
Updated data from phase 2 study reveals survival benefit
Rishi Sunak joins Prostate Cancer Research as an ambassador
Former UK PM advocates for national screening programme
Dubai garden blooms with Boehringer Ingelheim’s lung disease campaign
Awareness of interstitial lung disease raised at Miracle Garden
ICR researchers develop blood test to uncover how childhood tumours adapt
It is hoped that the approach will lead to more targeted treatments for childhood cancers
FDA approves Deciphera’s Romvimza for rare tumour type
Tenosynovial giant cell tumours can cause pain, stiffness, swelling and movement limitations
UK study highlights importance of GP data in understanding atrial fibrillation
The common heart condition affects approximately 1.5 million people in the UK
NHS England launches first-ever breast cancer screening campaign
New data has shown that around a third of women do not attend screenings after being invited
Cambridge scientists develop ‘super test’ for prostate cancer
New test aims to revolutionise prostate cancer screening
Bath researchers awarded Wellcome grant for psychotic disorder study
New funding to investigate cognitive decline and brain ageing
Andembry treatment approved across Europe
Significant progress for hereditary angioedema condition
Illuccix therapy gets approval in the UK
Imaging agent to improve prostate cancer detection
